165 related articles for article (PubMed ID: 15624449)
1. The broadening use of leflunomide in clinical practice.
Kiely PD
Hosp Med; 2004 Dec; 65(12):735-9. PubMed ID: 15624449
[TBL] [Abstract][Full Text] [Related]
2. Leflunomide in clinical practice.
Pinto P; Dougados M
Acta Reumatol Port; 2006; 31(3):215-24. PubMed ID: 17094333
[TBL] [Abstract][Full Text] [Related]
3. [Leflunomide (Arava) in the treatment of rheumatoid arthritis].
Kaliterna DM
Reumatizam; 2007; 54(2):67-8. PubMed ID: 18351143
[No Abstract] [Full Text] [Related]
4. Leflunomide for rheumatoid arthritis.
Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
[TBL] [Abstract][Full Text] [Related]
5. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
[No Abstract] [Full Text] [Related]
6. Leflunomide for the treatment of rheumatoid arthritis and autoimmunity.
Sanders S; Harisdangkul V
Am J Med Sci; 2002 Apr; 323(4):190-3. PubMed ID: 12003373
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide.
Cannon GW; Kremer JM
Rheum Dis Clin North Am; 2004 May; 30(2):295-309, vi. PubMed ID: 15172042
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators' Group.
Rozman B
J Rheumatol Suppl; 1998 Jul; 53():27-32. PubMed ID: 9666415
[TBL] [Abstract][Full Text] [Related]
9. Leflunomide combined with conventional disease-modifying antirheumatic drugs or biologics in patients with rheumatoid arthritis.
Combe B
Joint Bone Spine; 2006 Dec; 73(6):587-90. PubMed ID: 17071123
[No Abstract] [Full Text] [Related]
10. Pharmacotherapy: Is there a place for leflunomide in the treatment of RA?
Osiri M
Nat Rev Rheumatol; 2010 Jul; 6(7):387-9. PubMed ID: 20596051
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
Smolen JS; Kalden JR; Scott DL; Rozman B; Kvien TK; Larsen A; Loew-Friedrich I; Oed C; Rosenburg R
Lancet; 1999 Jan; 353(9149):259-66. PubMed ID: 9929017
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.
Herrmann ML; Schleyerbach R; Kirschbaum BJ
Immunopharmacology; 2000 May; 47(2-3):273-89. PubMed ID: 10878294
[TBL] [Abstract][Full Text] [Related]
13. Leflunomide, a new disease-modifying anti-rheumatic drug and the never ending rheumatoid arthritis story.
Smolen JS; Graninger WB; Emery P
Rheumatology (Oxford); 2000 Jul; 39(7):689-92. PubMed ID: 10908683
[No Abstract] [Full Text] [Related]
14. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
15. Leflunomide and methotrexate combination therapy in daily clinical practice.
Dendooven A; De Rycke L; Verhelst X; Mielants H; Veys EM; De Keyser F
Ann Rheum Dis; 2006 Jun; 65(6):833-4. PubMed ID: 16699056
[No Abstract] [Full Text] [Related]
16. Treatment of Felty's syndrome with leflunomide.
Talip F; Walker N; Khan W; Zimmermann B
J Rheumatol; 2001 Apr; 28(4):868-70. PubMed ID: 11327265
[TBL] [Abstract][Full Text] [Related]
17. The hypouricemiant effect of leflunomide.
Arida D; Silva L; Skare TL
Joint Bone Spine; 2014 May; 81(3):273-4. PubMed ID: 24289959
[No Abstract] [Full Text] [Related]
18. Leflunomide: a new DMARD for rheumatoid arthritis.
Emery P
Hosp Med; 2000 May; 61(5):344-7. PubMed ID: 10953742
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of rheumatoid and psoriatic arthritis--review of leflunomide].
Babić-Naglić D; Anić B; Novak S; Grazio S; Martinavić Kaliterna D
Reumatizam; 2010; 57(2):161-2. PubMed ID: 21875023
[No Abstract] [Full Text] [Related]
20. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 5. Leflunomide and mizoribine].
Sawada T
Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2929-35. PubMed ID: 22175133
[No Abstract] [Full Text] [Related]
[Next] [New Search]
